Harrow (HROW) Share-based Compensation (2010 - 2026)

Harrow's (HROW) quarterly Share-based Compensation came in at $3.8 million in Q1 2026, down 15.78% year-on-year from $4.6 million in Q1 2025, and up 0.97% quarter-over-quarter from $3.8 million in Q4 2025.

Harrow (HROW) Share-based Compensation (2010 - 2026) Analysis & Trends

Harrow's Share-based Compensation history runs 17 years deep, the most recent figure standing at $3.8 million for Q1 2026.

  • On a quarterly basis, Share-based Compensation fell 15.78% year-over-year to $3.8 million in Q1 2026; TTM through Mar 2026 was $11.8 million, a 34.57% decrease from a year earlier, with the FY2025 full-year figure at $12.5 million, down 29.04% from the prior year.
  • Share-based Compensation climbed to $3.8 million in Q1 2026 per HROW's latest filing, from $3.8 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $5.8 million in Q4 2022 and bottomed at $875000.0 in Q2 2025.
  • The 5-year median for Share-based Compensation is $4.2 million (2024), against an average of $3.6 million.
  • Across the five-year window, Share-based Compensation soared 173.57% in 2022 and slumped 79.51% in 2025, its largest moves.
  • Year by year, Share-based Compensation stood at $5.8 million in 2022, then fell by 27.84% to $4.2 million in 2023, then climbed by 14.83% to $4.8 million in 2024, then dropped by 20.73% to $3.8 million in 2025, then increased by 0.97% to $3.8 million in 2026.
  • Per Business Quant, the three latest HROW Share-based Compensation figures stand at $3.8 million (Q1 2026), $3.8 million (Q4 2025), and $3.3 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 43.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 25.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 125.69 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 58.30 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 56.50 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 55.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 21.00 Mn
10 Harrow 1.56 Bn 1.47 Bn 27.05 Mn 3.84 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.84 Mn
Mar 31, 2026 3.84 Mn
Dec 31, 2025 3.80 Mn
Dec 31, 2025 3.80 Mn
Sep 30, 2025 3.27 Mn
Sep 30, 2025 3.27 Mn
Jun 30, 2025 875,000.00
Jun 30, 2025 875,000.00
Mar 31, 2025 4.56 Mn
Mar 31, 2025 4.56 Mn
Dec 31, 2024 4.79 Mn
Dec 31, 2024 4.79 Mn
Sep 30, 2024 4.39 Mn
Sep 30, 2024 4.39 Mn
Jun 30, 2024 4.27 Mn
Jun 30, 2024 4.27 Mn
Mar 31, 2024 4.17 Mn
Mar 31, 2024 4.17 Mn
Dec 31, 2023 4.18 Mn
Dec 31, 2023 4.18 Mn